← Leaderboards
Junga "alexa" Woo
Case Western Reserve University
$6,163,380
Attributed
$8,331,295
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,331,295 · 5
By mechanism
R01$4,476,860 · 3
RF1$3,854,435 · 2
Top collaborators
- David E Kang8 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Yu Luo$7,531,702
- Pamela B Davis$114,848,546
- Darwin Jeyaraj$387,180
- Stanley Adoro$1,747,993
- Tsan Sam Xiao$5,838,475
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposBiochemicalCellsMediatingPathway InteractionsElectrophysiology (Science)InsightSynaptic PlasticityNeuronsIn VivoBehavioralBrainAutophagocytosisPathogenesisPathologyMolecularNeuroinflammationProteinsLysosomesIn VitroBiologicalLinkImpairmentImpaired Cognition
Grant awards (14)
Deubiquitinase USP19 in TDP-43 pathogenesis.$595,610
R01 · FY2025 · NS
Decoding the BETA-arrestin2-LMBRD2 cascade in ALPHA-synuclein pathogenesis.$2,069,215
RF1 · FY2024 · NS · contact PI
Deubiquitinase USP11 in tau regulation and age-related tauopathy$402,500
R01 · FY2024 · AG
Deubiquitinase USP11 in tau regulation and age-related tauopathy$402,500
R01 · FY2023 · AG
Novel role of β-arrestins in Tauopathy$402,500
R01 · FY2023 · AG · contact PI
Deubiquitinase USP19 in TDP-43 pathogenesis.$1,785,220
RF1 · FY2022 · NS
Deubiquitinase USP11 in tau regulation and age-related tauopathy$402,500
R01 · FY2022 · AG
Novel role of β-arrestins in Tauopathy$402,500
R01 · FY2022 · AG · contact PI
Novel role of β-arrestins in Tauopathy$373,750
R01 · FY2021 · AG · contact PI
Deubiquitinase USP11 in tau regulation and age-related tauopathy$341,530
R01 · FY2021 · AG
Deubiquitinase USP11 in tau regulation and age-related tauopathy$32,220
R01 · FY2021 · AG
Deubiquitinase USP11 in tau regulation and age-related tauopathy$373,750
R01 · FY2020 · AG
Novel role of β-arrestins in Tauopathy$373,750
R01 · FY2020 · AG · contact PI
Novel role of β-arrestins in Tauopathy$373,750
R01 · FY2019 · AG · contact PI